ArticleBMC pregnancy and childbirth2025
Genetic and clinical features of microcephaly in a prenatal cohort.
Article in BMC pregnancy and childbirth, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundFetal microcephaly, defined as a small head circumference in utero or at birth, is a rare but clinically significant condition that may be associated with an increased risk of neurodevelopmental delay and impairment. However, the comprehensive analysis of multiple genetic testing methods for fetal microcephaly remains limited. This study aimed to summarize the clinical characteristics, ultrasound phenotypes, and genetic etiologies of prenatally diagnosed microcephaly.
methodsA single-center retrospective study was performed on fetuses with microcephaly. A total of 197 fetuses with microcephaly undergoing invasive prenatal diagnosis were recruited. Cytogenetic and monogenic abnormalities were investigated using karyotyping, chromosomal microarray analysis (CMA), copy number variant sequencing (CNV-seq) and whole exome sequencing (WES) were further analyzed.
resultsAmong the 197 fetuses, 48.7% (96/197) had isolated microcephaly, while 51.3% (101/197) had non-isolated microcephaly. Within the non-isolated group, 24.9% (49/197) presented soft markers and 10.2% (20/197) exhibited structural defects. The incidences of chromosomal abnormalities (12.9%, 13/101) and pathogenic CNVs (6.9%, 7/101) were both higher in nonisolated fetuses than those in isolated fetuses. Significant differences were observed in the rate of chromosomal abnormalities across the borderline, moderate and severe microcephaly subgroups, and pCNVs were detected more commonly in the severe subgroup than in the borderline or moderate subgroup. Trio-WES, performed in 24 cases, revealed single gene variants including the POGZ gene, which was associated with the phenotype of microcephaly. The overall rate of adverse pregnancy outcomes was 33.1% (57/172), excluding ongoing pregnancies and cases lost to follow-up.
conclusionsFetal microcephaly represents a genotypically and phenotypically heterogeneous disorder. The comprehensive application of multiple genetic testing approaches provides an effective and essential strategy for the prenatal diagnosis of the diverse etiologies underlying fetal microcephaly.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.